Discovery of 3-Amino-1<i>H</i>-pyrazole-Based Kinase Inhibitors to Illuminate the Understudied PCTAIRE Family

The PCTAIRE subfamily belongs to the CDK (cyclin-dependent kinase) family and represents an understudied class of kinases of the dark kinome. They exhibit a highly conserved binding pocket and are activated by cyclin Y binding. CDK16 is targeted to the plasma membrane after binding to <i>N<...

Full description

Bibliographic Details
Main Authors: Jennifer Alisa Amrhein, Lena Marie Berger, Amelie Tjaden, Andreas Krämer, Lewis Elson, Tuomas Tolvanen, Daniel Martinez-Molina, Astrid Kaiser, Manfred Schubert-Zsilavecz, Susanne Müller, Stefan Knapp, Thomas Hanke
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/23/23/14834
_version_ 1797463060402667520
author Jennifer Alisa Amrhein
Lena Marie Berger
Amelie Tjaden
Andreas Krämer
Lewis Elson
Tuomas Tolvanen
Daniel Martinez-Molina
Astrid Kaiser
Manfred Schubert-Zsilavecz
Susanne Müller
Stefan Knapp
Thomas Hanke
author_facet Jennifer Alisa Amrhein
Lena Marie Berger
Amelie Tjaden
Andreas Krämer
Lewis Elson
Tuomas Tolvanen
Daniel Martinez-Molina
Astrid Kaiser
Manfred Schubert-Zsilavecz
Susanne Müller
Stefan Knapp
Thomas Hanke
author_sort Jennifer Alisa Amrhein
collection DOAJ
description The PCTAIRE subfamily belongs to the CDK (cyclin-dependent kinase) family and represents an understudied class of kinases of the dark kinome. They exhibit a highly conserved binding pocket and are activated by cyclin Y binding. CDK16 is targeted to the plasma membrane after binding to <i>N</i>-myristoylated cyclin Y and is highly expressed in post-mitotic tissues, such as the brain and testis. Dysregulation is associated with several diseases, including breast, prostate, and cervical cancer. Here, we used the <i>N</i>-(1<i>H</i>-pyrazol-3-yl)pyrimidin-4-amine moiety from the promiscuous inhibitor <b>1</b> to target CDK16, by varying different residues. Further optimization steps led to <b>43d</b>, which exhibited high cellular potency for CDK16 (EC<sub>50</sub> = 33 nM) and the other members of the PCTAIRE and PFTAIRE family with 20–120 nM and 50–180 nM, respectively. A DSF screen against a representative panel of approximately 100 kinases exhibited a selective inhibition over the other kinases. In a viability assessment, <b>43d</b> decreased the cell count in a dose-dependent manner. A FUCCI cell cycle assay revealed a G2/M phase cell cycle arrest at all tested concentrations for <b>43d</b>, caused by inhibition of CDK16.
first_indexed 2024-03-09T17:46:19Z
format Article
id doaj.art-3d8f7e84ed404e629202c35e560411a4
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-09T17:46:19Z
publishDate 2022-11-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-3d8f7e84ed404e629202c35e560411a42023-11-24T11:08:44ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672022-11-0123231483410.3390/ijms232314834Discovery of 3-Amino-1<i>H</i>-pyrazole-Based Kinase Inhibitors to Illuminate the Understudied PCTAIRE FamilyJennifer Alisa Amrhein0Lena Marie Berger1Amelie Tjaden2Andreas Krämer3Lewis Elson4Tuomas Tolvanen5Daniel Martinez-Molina6Astrid Kaiser7Manfred Schubert-Zsilavecz8Susanne Müller9Stefan Knapp10Thomas Hanke11Institute of Pharmaceutical Chemistry, Goethe-University Frankfurt, Max-von-Laue-Str. 9, 60438 Frankfurt am Main, GermanyInstitute of Pharmaceutical Chemistry, Goethe-University Frankfurt, Max-von-Laue-Str. 9, 60438 Frankfurt am Main, GermanyInstitute of Pharmaceutical Chemistry, Goethe-University Frankfurt, Max-von-Laue-Str. 9, 60438 Frankfurt am Main, GermanyInstitute of Pharmaceutical Chemistry, Goethe-University Frankfurt, Max-von-Laue-Str. 9, 60438 Frankfurt am Main, GermanyInstitute of Pharmaceutical Chemistry, Goethe-University Frankfurt, Max-von-Laue-Str. 9, 60438 Frankfurt am Main, GermanyDivision of Rheumatology, Department of Medicine Solna, Karolinska University Hospital and Karolinska Institute, Solnavägen 1, 17177 Solna, SwedenPelago Bioscience AB, Scheeles Väg 1, 17165 Solna, SwedenInstitute of Pharmaceutical Chemistry, Goethe-University Frankfurt, Max-von-Laue-Str. 9, 60438 Frankfurt am Main, GermanyInstitute of Pharmaceutical Chemistry, Goethe-University Frankfurt, Max-von-Laue-Str. 9, 60438 Frankfurt am Main, GermanyInstitute of Pharmaceutical Chemistry, Goethe-University Frankfurt, Max-von-Laue-Str. 9, 60438 Frankfurt am Main, GermanyInstitute of Pharmaceutical Chemistry, Goethe-University Frankfurt, Max-von-Laue-Str. 9, 60438 Frankfurt am Main, GermanyInstitute of Pharmaceutical Chemistry, Goethe-University Frankfurt, Max-von-Laue-Str. 9, 60438 Frankfurt am Main, GermanyThe PCTAIRE subfamily belongs to the CDK (cyclin-dependent kinase) family and represents an understudied class of kinases of the dark kinome. They exhibit a highly conserved binding pocket and are activated by cyclin Y binding. CDK16 is targeted to the plasma membrane after binding to <i>N</i>-myristoylated cyclin Y and is highly expressed in post-mitotic tissues, such as the brain and testis. Dysregulation is associated with several diseases, including breast, prostate, and cervical cancer. Here, we used the <i>N</i>-(1<i>H</i>-pyrazol-3-yl)pyrimidin-4-amine moiety from the promiscuous inhibitor <b>1</b> to target CDK16, by varying different residues. Further optimization steps led to <b>43d</b>, which exhibited high cellular potency for CDK16 (EC<sub>50</sub> = 33 nM) and the other members of the PCTAIRE and PFTAIRE family with 20–120 nM and 50–180 nM, respectively. A DSF screen against a representative panel of approximately 100 kinases exhibited a selective inhibition over the other kinases. In a viability assessment, <b>43d</b> decreased the cell count in a dose-dependent manner. A FUCCI cell cycle assay revealed a G2/M phase cell cycle arrest at all tested concentrations for <b>43d</b>, caused by inhibition of CDK16.https://www.mdpi.com/1422-0067/23/23/14834CDK16cell cycleFUCCIkinasekinase inhibitorNanoBRET
spellingShingle Jennifer Alisa Amrhein
Lena Marie Berger
Amelie Tjaden
Andreas Krämer
Lewis Elson
Tuomas Tolvanen
Daniel Martinez-Molina
Astrid Kaiser
Manfred Schubert-Zsilavecz
Susanne Müller
Stefan Knapp
Thomas Hanke
Discovery of 3-Amino-1<i>H</i>-pyrazole-Based Kinase Inhibitors to Illuminate the Understudied PCTAIRE Family
International Journal of Molecular Sciences
CDK16
cell cycle
FUCCI
kinase
kinase inhibitor
NanoBRET
title Discovery of 3-Amino-1<i>H</i>-pyrazole-Based Kinase Inhibitors to Illuminate the Understudied PCTAIRE Family
title_full Discovery of 3-Amino-1<i>H</i>-pyrazole-Based Kinase Inhibitors to Illuminate the Understudied PCTAIRE Family
title_fullStr Discovery of 3-Amino-1<i>H</i>-pyrazole-Based Kinase Inhibitors to Illuminate the Understudied PCTAIRE Family
title_full_unstemmed Discovery of 3-Amino-1<i>H</i>-pyrazole-Based Kinase Inhibitors to Illuminate the Understudied PCTAIRE Family
title_short Discovery of 3-Amino-1<i>H</i>-pyrazole-Based Kinase Inhibitors to Illuminate the Understudied PCTAIRE Family
title_sort discovery of 3 amino 1 i h i pyrazole based kinase inhibitors to illuminate the understudied pctaire family
topic CDK16
cell cycle
FUCCI
kinase
kinase inhibitor
NanoBRET
url https://www.mdpi.com/1422-0067/23/23/14834
work_keys_str_mv AT jenniferalisaamrhein discoveryof3amino1ihipyrazolebasedkinaseinhibitorstoilluminatetheunderstudiedpctairefamily
AT lenamarieberger discoveryof3amino1ihipyrazolebasedkinaseinhibitorstoilluminatetheunderstudiedpctairefamily
AT amelietjaden discoveryof3amino1ihipyrazolebasedkinaseinhibitorstoilluminatetheunderstudiedpctairefamily
AT andreaskramer discoveryof3amino1ihipyrazolebasedkinaseinhibitorstoilluminatetheunderstudiedpctairefamily
AT lewiselson discoveryof3amino1ihipyrazolebasedkinaseinhibitorstoilluminatetheunderstudiedpctairefamily
AT tuomastolvanen discoveryof3amino1ihipyrazolebasedkinaseinhibitorstoilluminatetheunderstudiedpctairefamily
AT danielmartinezmolina discoveryof3amino1ihipyrazolebasedkinaseinhibitorstoilluminatetheunderstudiedpctairefamily
AT astridkaiser discoveryof3amino1ihipyrazolebasedkinaseinhibitorstoilluminatetheunderstudiedpctairefamily
AT manfredschubertzsilavecz discoveryof3amino1ihipyrazolebasedkinaseinhibitorstoilluminatetheunderstudiedpctairefamily
AT susannemuller discoveryof3amino1ihipyrazolebasedkinaseinhibitorstoilluminatetheunderstudiedpctairefamily
AT stefanknapp discoveryof3amino1ihipyrazolebasedkinaseinhibitorstoilluminatetheunderstudiedpctairefamily
AT thomashanke discoveryof3amino1ihipyrazolebasedkinaseinhibitorstoilluminatetheunderstudiedpctairefamily